Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study

DOI: 10.1186/s12969-018-0258-5

Keywords: Osteoporosis, Bone loss, Alendronate, Glucocorticoid, Childhood-onset rheumatic disease

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s12969-018-0258-5) contains supplementary material, which is available to authorized users

Full-Text